Amerisafe (AMSF) reported Q3 earnings of $0.55 per share, aligning with consensus but down from $0.58 year-over-year, while revenues of $77.86 million missed expectations by 0.53% and marked the fourth consecutive revenue miss. The company's stock has significantly underperformed the S&P 500 year-to-date, declining 21.2%, and unfavorable earnings estimate revisions have led to a Zacks Rank #4 (Sell), suggesting anticipated near-term underperformance. This outlook is further compounded by the Insurance - Accident and Health industry ranking in the bottom third of Zacks industries.
Amerisafe (AMSF) reported Q3 EPS of $0.55, aligning with consensus but representing a year-over-year decline from $0.58. Revenues of $77.86 million missed the Zacks Consensus Estimate by 0.53%, marking the fourth consecutive quarter the company has failed to beat revenue expectations. This follows a prior quarter EPS surprise of -3.64%, despite the company surpassing EPS estimates in two of the last four quarters. The stock has significantly underperformed the market, losing 21.2% year-to-date against the S&P 500's 17.2% gain. An unfavorable earnings estimate revisions trend has led to a Zacks Rank #4 (Sell), signaling anticipated near-term underperformance. The sustainability of any immediate price movement will depend heavily on management's commentary during the earnings call. Further compounding the outlook, the Insurance - Accident and Health industry, to which AMSF belongs, ranks in the bottom 34% of Zacks industries. This industry weakness historically correlates with underperformance for constituent stocks. Current consensus estimates project Q4 EPS of $0.58 on $80.12 million in revenues and full-year EPS of $2.25 on $310.28 million.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment
